More than 40 large volume wearable injectors are presently available / under development ::By RootsAnalysis::
Theconvenience of subcutaneous route of drug administration and the reformulationof intravenous drugs, reaching patent expiry, for SC delivery has provided animpetus to the development of large volume wearable injectors. In fact, accordingto the experts in this field, the industry is putting in significant efforts todevelop efficient and effective drug-device combinations to deliver largevolumes of drugs over a convenient period of time.
To order this 540+ page report, which features 175+ figuresand 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html
The USD 2.7 billion and USD 600 million (by 2030) financial opportunitywithin the large volume wearable injectors market for the delivery ofinsulin and of non-insulin drugs,respectively, has been analyzed across the following segments:
§ Type of Device
- Patch Pump / Injectors
- Infusion Pump / Injectors
§ Product Usability
- Disposable
- Re-usable
§ Therapeutic Area (fornon-insulin drugs)
- Neurological Disorders
- Cardiovascular Disorders
- Oncological Disorders
- Infectious Disorders
§ Key geographicalregions
- North America
- Europe
- Asia Pacific
ThereportLarge Volume Wearable Injectors Market (5th Edition), 2020-2030:Focus on Bolus, Basal and Continuous Delivery Devices.” features the following companies, which we identified tobe key players in this domain:
§ Becton Dickinson
§ Bespak (subsidiary of ConsortMedical)
§ CeQur
§ Debiotech
§ Eli Lilly
§ Enable Injections
§ Insulet
§ Medtronic
§ PharmaSens
§ Roche
§ SOOIL Development
§ Sonceboz
§ Sensile Medical (acquired byGerresheimer)
§ SteadyMed Therapeutics (acquiredby United Therapeutics)
§ Tandem Diabetes Care
§ Weibel CDS (acquired by SHLMedical)
§ West Pharmaceutical Services
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Large Volume Wearable Injectors: Current Market Landscape
5. Product Competitiveness Analysis
6. Large Volume Wearable Injectors: Key Players
7. Drug Device Combinations: Tabulated Profiles
8. Partnerships and Collaborations
9. Key Acquisition Targets
10. Patent Analysis
11. Large Volume Wearable Injectors: Likely Drug Candidates
12. Emerging Trends on Social Media
13. Clinical Trial Analysis
14. Case Study: Role of CMOs in Device Development and Manufacturing
15. Regulatory and Reimbursement Landscape for Medical Devices
16. Market Sizing and Opportunity Analysis
17. SWOT Analysis
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations
Topurchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
